LAMC2 + Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3 / STAT3 / CD44 Axis

Cancer Science · Published 2026-08-05 · DOI 10.1111/cas.70492

Free full text

Authors (18)

Yutong Chen, Yunzhong Jiang, Zezhong Yang, Minxuan Jing, Wentai Wu, Jiale He, Lu Wang, Minghai Ma, Yaodong Zhang, Min Wang, Jianpeng Li, Yuanchun Pu, Bingliang He, Yanjia Liu, Kaibo Mi, Hang Liu, Mengzhao Zhang, Jinhai Fan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, Y., Jiang, Y., Yang, Z., et al. (2026). LAMC2 + Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3 / STAT3 / CD44 Axis. Cancer Science. https://doi.org/10.1111/cas.70492

Related articles

• LMTK2 Inhibits Metastasis of Colon Cancer Cells Through p38 MAPK · Cancer Science · 2026 · Same journal
• Targeting the NR3C1 ‐ ACSL4 Axis Triggers Ferroptosis to Overcome Radioresistance in Prostate Cancer · Cancer Science · 2026 · Same journal
• New Treatment Strategy and Future Research Direction for BRAF ‐Mutated Cancer · Cancer Science · 2026 · Same journal
• Final Analysis of Neoadjuvant Sintilimab Plus Chemotherapy in IB – IIIA Non‐Small‐Cell Lung Cancer: Phase 2 neoSCORE Trial · Cancer Science · 2026 · Same journal
• circMAN1A2 as an Isoform‐Resolved Circular RNA Hub in Cancer · Cancer Science · 2026 · Same journal
• RASD 2 Drives Renal Clear Cell Carcinoma Progression via RAF 1 (Ser338) Phosphorylation · Cancer Science · 2026 · Same journal
• Bile‐Derived Exosomal miR ‐196a/‐196b as Diagnostic Biomarkers Associated With Tumor Progression in Biliary Tract Cancer · Cancer Science · 2026 · Same journal
• Transporter‐Associated Therapeutic Efficacy of an SMVT ‐Targeted Boron Carrier in Boron Neutron Capture Therapy · Cancer Science · 2026 · Same journal
• Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer · Cancer Science · 2026 · Same journal
• Ketogenic Diet and β‐Hydroxybutyrate Suppress Bladder Cancer Growth and Enhance Anti‐ PD ‐ L1 Immunotherapy Efficacy · Cancer Science · 2026 · Same journal